3OD – Once-daily (OD) TDF-containing HAART in HIV-1-infected former IVDU-patients receiving opiate substitution: efficacy, tolerability and adherence

Esser, S; Staszewski, S; Haberl, AE; Mulcahy, F; Gölz, J; Lazzarin, A; Teofilo, E; Vera, J; Körber, A; Ranneberg, B; Gallo, L

doi:10.1186/1758-2652-11-S1-P76

Journal of the International AIDS Society

Article metrics
Last updated: Wed, 24 Apr 2024 12:30:30 Z

3OD – Once-daily (OD) TDF-containing HAART in HIV-1-infected former IVDU-patients receiving opiate substitution: efficacy, tolerability and adherence

Access & Citations

934

Article Accesses
0

Web of Science
1

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.